Zymeworks
Padmapriya Padmanabhan has a strong background in biomedical research and regulatory affairs, with experience working as a clinical research coordinator and medical writer at various companies. Padmapriya also has interned at organizations focusing on nanomechanical characterization of biomaterials and chemical analysis of drugs. Padmapriya holds a Master of Science degree in Biomedical Regulatory Affairs from the University of Washington and a Bachelor's degree in Biotechnology from Visvesvaraya Technological University.
Zymeworks
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.